There has been some debate about how Aipac phase 3 is going to be funded. Do people really think that a clinical trial will be planned and then management decides to have a meeting and discuss how it is going to be paid for. Immutep's management do actually know what they are doing and I think people on here and other forums doubt their ability.
There has been some debate about how Aipac phase 3 is going to...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.010(2.50%) |
Mkt cap ! $559.2M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.5¢ | 38.5¢ | $561.9K | 1.436M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 108152 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 58921 | 16 |
View Market Depth
| Last trade - 11.33am 04/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |